X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare FDC LTD. with Sun Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs SUN PHARMA - Comparison Results

SUN PHARMA 
   Change

Sun Pharma holds 3.7% share of the domestic pharma market (as per the latest ORG IMS MAT data) and has a strong presence in the lifestyle therapeutic segments. The company started focusing on the exports market in FY02, when it increased its stake to... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. SUN PHARMA FDC LTD./
SUN PHARMA
 
P/E (TTM) x 28.9 25.9 111.7% View Chart
P/BV x 6.0 3.8 159.4% View Chart
Dividend Yield % 0.8 0.6 129.2%  

Financials

 FDC LTD.   SUN PHARMA
EQUITY SHARE DATA
    FDC LTD.
Mar-14
SUN PHARMA
Mar-17
FDC LTD./
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs144842 17.0%   
Low Rs79572 13.8%   
Sales per share (Unadj.) Rs47.6131.6 36.1%  
Earnings per share (Unadj.) Rs7.632.7 23.3%  
Cash flow per share (Unadj.) Rs9.038.0 23.7%  
Dividends per share (Unadj.) Rs2.253.50 64.3%  
Dividend yield (eoy) %2.00.5 408.7%  
Book value per share (Unadj.) Rs47.5152.7 31.1%  
Shares outstanding (eoy) m177.832,399.26 7.4%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.35.4 43.5%   
Avg P/E ratio x14.621.6 67.6%  
P/CF ratio (eoy) x12.318.6 66.3%  
Price / Book Value ratio x2.34.6 50.5%  
Dividend payout %29.610.7 276.3%   
Avg Mkt Cap Rs m19,7841,696,877 1.2%   
No. of employees `000NA17.5 0.0%   
Total wages/salary Rs m1,22149,023 2.5%   
Avg. sales/employee Rs ThNM18,028.3-  
Avg. wages/employee Rs ThNM2,798.8-  
Avg. net profit/employee Rs ThNM4,479.5-  
INCOME DATA
Net Sales Rs m8,459315,784 2.7%  
Other income Rs m3946,232 6.3%   
Total revenues Rs m8,852322,016 2.7%   
Gross profit Rs m2,070100,893 2.1%  
Depreciation Rs m24912,648 2.0%   
Interest Rs m313,998 0.8%   
Profit before tax Rs m2,18490,479 2.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m-22599 -226.5%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m60612,116 5.0%   
Profit after tax Rs m1,35378,462 1.7%  
Gross profit margin %24.531.9 76.6%  
Effective tax rate %27.713.4 207.1%   
Net profit margin %16.024.8 64.4%  
BALANCE SHEET DATA
Current assets Rs m4,355329,537 1.3%   
Current liabilities Rs m1,792178,870 1.0%   
Net working cap to sales %30.347.7 63.5%  
Current ratio x2.41.8 131.9%  
Inventory Days Days4479 56.3%  
Debtors Days Days2583 29.6%  
Net fixed assets Rs m3,025204,766 1.5%   
Share capital Rs m1792,399 7.4%   
"Free" reserves Rs m8,243363,997 2.3%   
Net worth Rs m8,453366,397 2.3%   
Long term debt Rs m1114,361 0.1%   
Total assets Rs m10,557614,102 1.7%  
Interest coverage x71.423.6 302.2%   
Debt to equity ratio x00 3.2%  
Sales to assets ratio x0.80.5 155.8%   
Return on assets %13.113.4 97.6%  
Return on equity %16.021.4 74.8%  
Return on capital %23.524.8 94.6%  
Exports to sales %13.30-   
Imports to sales %3.30-   
Exports (fob) Rs m1,126NA-   
Imports (cif) Rs m283NA-   
Fx inflow Rs m1,14644,118 2.6%   
Fx outflow Rs m35524,484 1.5%   
Net fx Rs m79119,634 4.0%   
CASH FLOW
From Operations Rs m1,48570,822 2.1%  
From Investments Rs m-620-42,216 1.5%  
From Financial Activity Rs m-753-22,854 3.3%  
Net Cashflow Rs m1136,107 1.8%  

Share Holding

Indian Promoters % 68.9 63.7 108.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.7 5.1 91.6%  
FIIs % 7.5 23.0 32.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.0 8.3 228.9%  
Shareholders   23,730 133,026 17.8%  
Pledged promoter(s) holding % 0.0 0.5 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   DIVIS LABORATORIES  WOCKHARDT LTD.  AUROBINDO PHARMA  PLETHICO PHARMA  GLENMARK PHARMA  

Compare FDC LTD. With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Global Stock Markets Rebound After Sharp Weekly Drop(RoundUp)

Global financial markets rallied this week and brushed aside a rise in global borrowing costs while the dollar hit its lowest level since 2014.

Related Views on News

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

Sun Pharma: Slow Growth Across Major Markets (Quarterly Results Update - Detailed)

Mar 11, 2017

Sun Pharma has announced its December quarter (3QFY17) results. The company has reported 8% YoY growth in sales and a decline of 4.7% YoY in the net profits.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

As the Market Corrects... It's Time to Buy More(Smart Contrarian)

Feb 5, 2018

The recent sell off in the stock market offers buying opportunity in some quality small caps.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

What Should Mutual Fund Investors Do After LTCG Tax Norms(Outside View)

Feb 6, 2018

PersonalFN explain what investors should after LTCG tax norms.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Feb 16, 2018 (Close)

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE FDC LTD. WITH

MARKET STATS